Guidance on home blood pressure monitoring: A statement of the HOPE Asia Network

Kazuomi Kario, Sungha Park, Peera Buranakitjaroen, Yook Chin Chia, Chen Huan Chen, Romeo Divinagracia, Satoshi Hoshide, Jinho Shin, Saulat Siddique, Jorge Sison, Arieska Ann Soenarta, Guru Prasad Sogunuru, Jam Chin Tay, Yuda Turana, Lawrence Wong, Yuqing Zhang, Ji Guang Wang

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Hypertension is an important modifiable cardiovascular risk factor and a leading cause of death throughout Asia. Effective prevention and control of hypertension in the region remain a significant challenge despite the availability of several regional and international guidelines. Out-of-office measurement of blood pressure (BP), including home BP monitoring (HBPM), is an important hypertension management tool. Home BP is better than office BP for predicting cardiovascular risk and HBPM should be considered for all patients with office BP ≥ 130/85 mm Hg. It is important that HBPM is undertaken using a validated device and patients are educated about how to perform HBPM correctly. During antihypertensive therapy, monitoring of home BP control and variability is essential, especially in the morning. This is because HBPM can facilitate the choice of individualized optimal therapy. The evidence and practice points in this document are based on the Hypertension Cardiovascular Outcome Prevention and Evidence (HOPE) Asia Network expert panel consensus recommendations for HBPM in Asia.

Original languageEnglish
Pages (from-to)456-461
Number of pages6
JournalJournal of Clinical Hypertension
Volume20
Issue number3
DOIs
Publication statusPublished - 2018 Mar

Fingerprint

Ambulatory Blood Pressure Monitoring
Hypertension
Blood Pressure
Antihypertensive Agents
Cause of Death
Guidelines
Equipment and Supplies
Therapeutics

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Cardiology and Cardiovascular Medicine

Cite this

Kario, K., Park, S., Buranakitjaroen, P., Chia, Y. C., Chen, C. H., Divinagracia, R., ... Wang, J. G. (2018). Guidance on home blood pressure monitoring: A statement of the HOPE Asia Network. Journal of Clinical Hypertension, 20(3), 456-461. https://doi.org/10.1111/jch.13216
Kario, Kazuomi ; Park, Sungha ; Buranakitjaroen, Peera ; Chia, Yook Chin ; Chen, Chen Huan ; Divinagracia, Romeo ; Hoshide, Satoshi ; Shin, Jinho ; Siddique, Saulat ; Sison, Jorge ; Soenarta, Arieska Ann ; Sogunuru, Guru Prasad ; Tay, Jam Chin ; Turana, Yuda ; Wong, Lawrence ; Zhang, Yuqing ; Wang, Ji Guang. / Guidance on home blood pressure monitoring : A statement of the HOPE Asia Network. In: Journal of Clinical Hypertension. 2018 ; Vol. 20, No. 3. pp. 456-461.
@article{efdae5ecadb641af991d43377f4ebb86,
title = "Guidance on home blood pressure monitoring: A statement of the HOPE Asia Network",
abstract = "Hypertension is an important modifiable cardiovascular risk factor and a leading cause of death throughout Asia. Effective prevention and control of hypertension in the region remain a significant challenge despite the availability of several regional and international guidelines. Out-of-office measurement of blood pressure (BP), including home BP monitoring (HBPM), is an important hypertension management tool. Home BP is better than office BP for predicting cardiovascular risk and HBPM should be considered for all patients with office BP ≥ 130/85 mm Hg. It is important that HBPM is undertaken using a validated device and patients are educated about how to perform HBPM correctly. During antihypertensive therapy, monitoring of home BP control and variability is essential, especially in the morning. This is because HBPM can facilitate the choice of individualized optimal therapy. The evidence and practice points in this document are based on the Hypertension Cardiovascular Outcome Prevention and Evidence (HOPE) Asia Network expert panel consensus recommendations for HBPM in Asia.",
author = "Kazuomi Kario and Sungha Park and Peera Buranakitjaroen and Chia, {Yook Chin} and Chen, {Chen Huan} and Romeo Divinagracia and Satoshi Hoshide and Jinho Shin and Saulat Siddique and Jorge Sison and Soenarta, {Arieska Ann} and Sogunuru, {Guru Prasad} and Tay, {Jam Chin} and Yuda Turana and Lawrence Wong and Yuqing Zhang and Wang, {Ji Guang}",
year = "2018",
month = "3",
doi = "10.1111/jch.13216",
language = "English",
volume = "20",
pages = "456--461",
journal = "Journal of Clinical Hypertension",
issn = "1524-6175",
publisher = "Wiley-Blackwell",
number = "3",

}

Kario, K, Park, S, Buranakitjaroen, P, Chia, YC, Chen, CH, Divinagracia, R, Hoshide, S, Shin, J, Siddique, S, Sison, J, Soenarta, AA, Sogunuru, GP, Tay, JC, Turana, Y, Wong, L, Zhang, Y & Wang, JG 2018, 'Guidance on home blood pressure monitoring: A statement of the HOPE Asia Network', Journal of Clinical Hypertension, vol. 20, no. 3, pp. 456-461. https://doi.org/10.1111/jch.13216

Guidance on home blood pressure monitoring : A statement of the HOPE Asia Network. / Kario, Kazuomi; Park, Sungha; Buranakitjaroen, Peera; Chia, Yook Chin; Chen, Chen Huan; Divinagracia, Romeo; Hoshide, Satoshi; Shin, Jinho; Siddique, Saulat; Sison, Jorge; Soenarta, Arieska Ann; Sogunuru, Guru Prasad; Tay, Jam Chin; Turana, Yuda; Wong, Lawrence; Zhang, Yuqing; Wang, Ji Guang.

In: Journal of Clinical Hypertension, Vol. 20, No. 3, 03.2018, p. 456-461.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Guidance on home blood pressure monitoring

T2 - A statement of the HOPE Asia Network

AU - Kario, Kazuomi

AU - Park, Sungha

AU - Buranakitjaroen, Peera

AU - Chia, Yook Chin

AU - Chen, Chen Huan

AU - Divinagracia, Romeo

AU - Hoshide, Satoshi

AU - Shin, Jinho

AU - Siddique, Saulat

AU - Sison, Jorge

AU - Soenarta, Arieska Ann

AU - Sogunuru, Guru Prasad

AU - Tay, Jam Chin

AU - Turana, Yuda

AU - Wong, Lawrence

AU - Zhang, Yuqing

AU - Wang, Ji Guang

PY - 2018/3

Y1 - 2018/3

N2 - Hypertension is an important modifiable cardiovascular risk factor and a leading cause of death throughout Asia. Effective prevention and control of hypertension in the region remain a significant challenge despite the availability of several regional and international guidelines. Out-of-office measurement of blood pressure (BP), including home BP monitoring (HBPM), is an important hypertension management tool. Home BP is better than office BP for predicting cardiovascular risk and HBPM should be considered for all patients with office BP ≥ 130/85 mm Hg. It is important that HBPM is undertaken using a validated device and patients are educated about how to perform HBPM correctly. During antihypertensive therapy, monitoring of home BP control and variability is essential, especially in the morning. This is because HBPM can facilitate the choice of individualized optimal therapy. The evidence and practice points in this document are based on the Hypertension Cardiovascular Outcome Prevention and Evidence (HOPE) Asia Network expert panel consensus recommendations for HBPM in Asia.

AB - Hypertension is an important modifiable cardiovascular risk factor and a leading cause of death throughout Asia. Effective prevention and control of hypertension in the region remain a significant challenge despite the availability of several regional and international guidelines. Out-of-office measurement of blood pressure (BP), including home BP monitoring (HBPM), is an important hypertension management tool. Home BP is better than office BP for predicting cardiovascular risk and HBPM should be considered for all patients with office BP ≥ 130/85 mm Hg. It is important that HBPM is undertaken using a validated device and patients are educated about how to perform HBPM correctly. During antihypertensive therapy, monitoring of home BP control and variability is essential, especially in the morning. This is because HBPM can facilitate the choice of individualized optimal therapy. The evidence and practice points in this document are based on the Hypertension Cardiovascular Outcome Prevention and Evidence (HOPE) Asia Network expert panel consensus recommendations for HBPM in Asia.

UR - http://www.scopus.com/inward/record.url?scp=85043453803&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043453803&partnerID=8YFLogxK

U2 - 10.1111/jch.13216

DO - 10.1111/jch.13216

M3 - Article

C2 - 29450979

AN - SCOPUS:85043453803

VL - 20

SP - 456

EP - 461

JO - Journal of Clinical Hypertension

JF - Journal of Clinical Hypertension

SN - 1524-6175

IS - 3

ER -